No valuation for DISCO Pharmaceuticals is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($41.8M) and the funding record below are the closest available signals.
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for DISCO Pharmaceuticals
- ·The full record, as it builds
Funding history
No funding rounds for DISCO Pharmaceuticals are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
How DISCO Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For DISCO Pharmaceuticals, we compose those signals into the PA Mark — a weighted composite of 2 recent pricing inputs, decayed by age and reset on new rounds. The implied valuation multiplies the mark by shares outstanding. Full methodology →
Frequently asked
- How much has DISCO Pharmaceuticals raised?
- DISCO Pharmaceuticals has raised $41.8M in total funding across its recorded rounds.